Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000455201 | SCV000540189 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
Labcorp Genetics |
RCV001510529 | SCV001717586 | benign | not provided | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001796054 | SCV002033613 | benign | Infantile liver failure syndrome 3 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000455201 | SCV002643458 | benign | not specified | 2020-07-30 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001510529 | SCV005270629 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004539924 | SCV004797720 | benign | RINT1-related disorder | 2024-04-02 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |